A:No treatment

2 trials

Sponsors

Shenzhen Hospital of Peking University, the 175th Hospital of PLA

Conditions

hepatitis Bthe Middle or Advaneed StageHepatoCellular Carcinoma(HCC)

Phase 4

Multi-channel Blood Exclusion for the Treatment of the Middle or Advaneed Stage HepatoCellular Carcinoma (HCC)

RecruitingChiCTR-TRC-13003746

the 175th Hospital of PLAthe Middle or Advaneed StageHepatoCellular Carcinoma(HCC)

Start: 2013-10-01Updated: 2017-04-18

A prospective study of the transformation rate of hepatitis B surface antigen of carriers of hepatitis B virus with HBV-DNA low load treated with Interferon

RecruitingChiCTR-OPC-14005267

Shenzhen Hospital of Peking Universityhepatitis B

Start: 2014-09-23Updated: 2017-04-18